Actym Therapeutics


Owner and operator of a preclinical immuno-oncology company intended to develop biologics to treat cancer. The company’s services mainly focus on engineering next generation immunotherapies to treat cancer, addressing many of the limitations associated with current therapies, enabling patients to have access to better form of cancer treatment.

626 Bancroft Way Suite A
Berkeley, CA 94710